Envafolimab (first subcutaneous injection PD-L1 mAb worldwide): Pan-cancer, multiple indications
3D189 (WT1): Cancer Vaccine for multiple indications
3D229 (GAS6/AXL): NSCLC/OC/Kidney cancer/Pancreatic Cancer
3D1002 (EP-4): Cancer pain/Chronic pain
3D1001 (COX-2): Cancer pain/Chronic pain
3D197: IO therapy targeting at multiple indications
3D185 (FGFR1/2/3): BTC/mUC
3D011 (PSMA+TKI): HCC/Prostate Cancer
3D057: Next generation IO therapy